Equipment Sterilisation

Radiation sterilisation involves exposing products to ionising radiation, such as gamma rays or electron beams, which damages the DNA of microorganisms, including bacteria, viruses, and fungi, preventing them from reproducing. This process is highly effective in inactivating a wide range of pathogens, including those resistant to traditional sterilisation methods like heat or chemicals. Radiation sterilisation offers several advantages over conventional methods. It can sterilise products in their final packaging, preventing recontamination. It is a cold process, making it suitable for heat-sensitive materials. It also provides uniform sterilisation, ensuring that all parts of the product are treated. This technique is widely used to sterilise medical devices, such as syringes, surgical instruments, and implants, as well as pharmaceuticals, food products, and consumer goods. It plays a crucial role in ensuring the safety and quality of these products.

Gamma Irradiation: Uses gamma rays from radioactive isotopes.
Electron Beam Irradiation: Uses accelerated electrons.
X-ray Irradiation: Uses high energy X-rays.

Medical Device Sterilisation: Sterilisation of syringes, surgical instruments, and implants.
Pharmaceutical Sterilisation: Sterilisation of drugs and medical supplies.
Food Product Sterilisation: Sterilisation of spices and other food products.
Packaging Material Sterilisation: Sterilisation of packaging to increase product shelf life.

Radiological risks depend on the radiation source. Source-based gamma irradiators require rigorous security and cradle-to-grave management of radioactive isotopes. Electricity-generated systems, such as e-beams and X-ray accelerators, pose a prompt radiation risk only during operation. Both require heavy shielding and automated safety interlocks to protect personnel from high-intensity radiation fields.

Source-based systems involve the significant costs of management of sources and complex logistics for international isotope transport. Electricity-generated systems demand high initial capital expenditure and a reliable, high-capacity electrical grid for operation. Both require specialised technical expertise and rigorous quality assurance to meet international healthcare standards.

There are no proliferation risks as there is no nuclear material involved in this application.